Moreover, the expression of Tmbim1 in hepatocytes significantly inhibits high-fat diet-induced insulin resistance, hepatic steatosis, and inflammation in mice, ultimately ameliorating NASH (89). This evidence concerns the gene TMBIM1 and metabolic dysfunction-associated steatohepatitis.